This activity is supported by educational grants from AbbVie, Inc.; Pfizer, Inc.; and Takeda Pharmaceuticals U.S.A., Inc.
Expiration Date: 1/20/2020
Inflammatory bowel disease (IBD) is a chronic, frequently progressive condition that affects approximately 1 to 1.3 million people in the United States. Substantial room…go to activity»
This activity is supported by independent educational grants from AbbVie; Pfizer, Inc.; and Takeda Pharmaceuticals U.S.A., Inc.
Expiration Date: 1/9/2020
Inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, is a chronic, relapsing condition characterized by an overly active immune response…go to activity»
No commercial support for this activity.
Expiration Date: 11/15/2019
This educational activity will utilize a case study to discuss the management of a 67-year-old man with heartburn who was taking antiplatelet therapy for acute coronary…go to activity»